Menu

Downloading protocols:
Please be aware that the size of the protocols are over 2MB and will take som time to open. It is recommended that you
right-click on “download protocol” and choose “save target as..”.
The protocols are only available as pdf-files. In order to read pdf-files you need the program Adobe Acrobat Reader.
It is a free and absolute essential program. – Click HERE and follow the instructions.
– Feel free to contact NSGOs webmaster if you have any questions (see contact address below).

Cervix

GOG-0240

A randomized phase III trial of cisplatin plus paclitaxel with and without NCI-supplied bevacizumab (NSC #704865, IND #7921) versus the non-platinum doublet, topotecan plus paclitaxel, with and without NCI-supplied bevacizumab, in stage IVB, recurrent or persistent carcinoma of the cervix.
Eligibility:
– Primary Stage IVB or recurrent/ persistent carcinoma of the cervix.
– Measurable disease.
– GOG performance status 0-1.
Download
protocol
(0,6 MB)
SHAPE TRIAL
(Simple Hysterectomy And Pelvic node dissection in Early cervix cancer)

Randomized trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low risk cervical cancer defined as lesions measuring less than 2cm with less than 50% stromal invasion.
Download
protocol
(0,4 MB)
THE OUTBACK TRIAL
(ANZGOG 0902)
A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone.
Download
protocol
(1,2 MB)

Ovary

AGO-OVAR OP.4
(AGO DESKTOP
OVAR III)
A RANDOMIZED MULTICENTER STUDY TO COMPARETHE EFFICACY OF ADDITIONAL TUMOR DEBULKINGSURGERY VERSUS CHEMOTHERAPY ALONE FORRECURRENT PLATINUM-SENSITIVE OVARIAN CANCER. Download
protocol synopsis
(0,3 MB)
AMG 386, –
TRINOVA-3- ENGOT-ov-2b
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers  
INOVATYON Phase III international, randomized study of Trabectedin plus Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin plus PLD in patients with ovarian cancer progressing within 6-12 months of last platinum.
mEOC A GCIG Intergroup multicentre trial of open label carboplatin and paclitaxel
+/- bevacizumab compared with oxaliplatin and capecitabine +/-
bevacizumab as first line chemotherapy in patients with
mucinous Epithelial Ovarian Cancer (mEOC).
 Download
protocol
(1,6 MB)
Symptom Benefit
(ANZGOG-0701)
Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Cancer?
Measuring subjective improvements as well as objective response to estimate the benefit of palliative chemotherapy in women with platinum resistant or refractory ovarian cancer.
 Download
protocol
(0,3 MB)